120 related articles for article (PubMed ID: 10456461)
1. Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
Feinberg WM; Macy E; Cornell ES; Nightingale SD; Pearce LA; Tracy RP; Bovill EG
Thromb Haemost; 1999 Jul; 82(1):100-3. PubMed ID: 10456461
[TBL] [Abstract][Full Text] [Related]
2. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
3. Influence of atrial fibrillation on coagulo-fibrinolytic markers in patients with cerebral infarction.
Ono N; Koyama T; Suehiro A; Oku K; Fujikake K; Kakishita E
Int Angiol; 1992; 11(4):298-303. PubMed ID: 1284251
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation: reducing stroke risk with low-dose anticoagulation.
Dalen JE
Geriatrics; 1994 May; 49(5):24-6, 29-32. PubMed ID: 8174938
[TBL] [Abstract][Full Text] [Related]
6. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
7. [Atrial fibrillation: incidence and prognostic factors of embolic risk].
Di Pasquale G; Ribani MA; Urbinati S; Passarelli P; Pinelli G
Cardiologia; 1993 Dec; 38(12 Suppl 1):291-300. PubMed ID: 8020029
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of plasmin-alpha2 antiplasmin complexes in unstable angina.
Bayés-Genís A; Guindo J; Oliver A; Badimon L; Fiol M; Mateo J; Souto JC; Dominguez JM; Fontcuberta J; Bayés de Luna A
Thromb Haemost; 1999 Jun; 81(6):865-8. PubMed ID: 10404758
[TBL] [Abstract][Full Text] [Related]
10. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
[TBL] [Abstract][Full Text] [Related]
11. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
[TBL] [Abstract][Full Text] [Related]
12. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations.
Tavakol M; Hassan KZ; Abdula RK; Briggs W; Oribabor CE; Tortolani AJ; Sacchi TJ; Lee LY; Heitner JF
Ann Thorac Surg; 2009 Sep; 88(3):802-7. PubMed ID: 19699901
[TBL] [Abstract][Full Text] [Related]
13. The stroke prevention in atrial fibrillation III study: rationale, design, and patient features.
Stroke Prevention In Atrial Fibrillation Investigators
J Stroke Cerebrovasc Dis; 1997; 6(5):341-53. PubMed ID: 17895032
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.
Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K
CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604
[TBL] [Abstract][Full Text] [Related]
15. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
Rockson SG; Albers GW
J Am Coll Cardiol; 2004 Mar; 43(6):929-35. PubMed ID: 15028346
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation in atrial fibrillation.
Anderson M; Kirk M
Med Health R I; 2004 Apr; 87(4):98-100. PubMed ID: 15168633
[TBL] [Abstract][Full Text] [Related]
17. AFFIRM and RACE trials: implications for the management of atrial fibrillation.
Blackshear JL; Safford RE; ;
Card Electrophysiol Rev; 2003 Dec; 7(4):366-9. PubMed ID: 15071255
[TBL] [Abstract][Full Text] [Related]
18. Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation.
Johnston JA; Cluxton RJ; Heaton PC; Guo JJ; Moomaw CJ; Eckman MH
Arch Intern Med; 2003 Jul; 163(14):1705-10. PubMed ID: 12885686
[TBL] [Abstract][Full Text] [Related]
19. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
[TBL] [Abstract][Full Text] [Related]
20. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
